nk cell marker
CD57 / B3GAT1 (Natural Killer Cell Marker); Clone NK-1 (Concentrate) |
|||
RA0356-C.1 | ScyTek Laboratories | 0.1 ml | 150 EUR |
CD57 / B3GAT1 (Natural Killer Cell Marker); Clone NK-1 (Concentrate) |
|||
RA0356-C.5 | ScyTek Laboratories | 0.5 ml | 296.4 EUR |
Monoclonal CD57 / B3GAT1 (Natural Killer Cell Marker) Antibody, Clone: NK/804 |
|||
AMM00761G | Leading Biology | 7 ml | 580.8 EUR |
Description: A Monoclonal antibody against Human CD57 / B3GAT1 (Natural Killer Cell Marker). The antibodies are raised in Mouse and are from clone NK/804. This antibody is applicable in IHC, IF |
|||
Monoclonal CD57 / B3GAT1 (Natural Killer Cell Marker) Antibody, Clone: NK-1 |
|||
AMM00752G | Leading Biology | 7 ml | 580.8 EUR |
Description: A Monoclonal antibody against Human CD57 / B3GAT1 (Natural Killer Cell Marker). The antibodies are raised in Mouse and are from clone NK-1. This antibody is applicable in IHC, IF |
|||
Granzyme B (NK/T-Cell Lymphoma Marker) Antibody |
|||
BNC941259-100 | Biotium | 100uL | 238.8 EUR |
Description: Primary antibody against Granzyme B (NK/T-Cell Lymphoma Marker), CF594 conjugate, Concentration: 0.1mg/mL |
|||
Granzyme B (NK/T-Cell Lymphoma Marker) Antibody |
|||
BNC941259-500 | Biotium | 500uL | 652.8 EUR |
Description: Primary antibody against Granzyme B (NK/T-Cell Lymphoma Marker), CF594 conjugate, Concentration: 0.1mg/mL |
|||
Granzyme B (NK/T-Cell Lymphoma Marker) Antibody |
|||
BNC801259-100 | Biotium | 100uL | 238.8 EUR |
Description: Primary antibody against Granzyme B (NK/T-Cell Lymphoma Marker), CF680 conjugate, Concentration: 0.1mg/mL |
|||
Granzyme B (NK/T-Cell Lymphoma Marker) Antibody |
|||
BNC801259-500 | Biotium | 500uL | 652.8 EUR |
Description: Primary antibody against Granzyme B (NK/T-Cell Lymphoma Marker), CF680 conjugate, Concentration: 0.1mg/mL |
|||
Granzyme B (NK/T-Cell Lymphoma Marker) Antibody |
|||
BNC811259-100 | Biotium | 100uL | 238.8 EUR |
Description: Primary antibody against Granzyme B (NK/T-Cell Lymphoma Marker), CF680R conjugate, Concentration: 0.1mg/mL |
|||
Granzyme B (NK/T-Cell Lymphoma Marker) Antibody |
|||
BNC811259-500 | Biotium | 500uL | 652.8 EUR |
Description: Primary antibody against Granzyme B (NK/T-Cell Lymphoma Marker), CF680R conjugate, Concentration: 0.1mg/mL |
|||
Granzyme B (NK/T-Cell Lymphoma Marker) Antibody |
|||
BNC701259-100 | Biotium | 100uL | 238.8 EUR |
Description: Primary antibody against Granzyme B (NK/T-Cell Lymphoma Marker), CF770 conjugate, Concentration: 0.1mg/mL |
|||
Granzyme B (NK/T-Cell Lymphoma Marker) Antibody |
|||
BNC701259-500 | Biotium | 500uL | 652.8 EUR |
Description: Primary antibody against Granzyme B (NK/T-Cell Lymphoma Marker), CF770 conjugate, Concentration: 0.1mg/mL |
|||
Granzyme B (NK/T-Cell Lymphoma Marker) Antibody |
|||
BNC881259-100 | Biotium | 100uL | 238.8 EUR |
Description: Primary antibody against Granzyme B (NK/T-Cell Lymphoma Marker), CF488A conjugate, Concentration: 0.1mg/mL |
|||
Granzyme B (NK/T-Cell Lymphoma Marker) Antibody |
|||
BNC881259-500 | Biotium | 500uL | 652.8 EUR |
Description: Primary antibody against Granzyme B (NK/T-Cell Lymphoma Marker), CF488A conjugate, Concentration: 0.1mg/mL |
|||
Granzyme B (NK/T-Cell Lymphoma Marker) Antibody |
|||
BNC051259-100 | Biotium | 100uL | 238.8 EUR |
Description: Primary antibody against Granzyme B (NK/T-Cell Lymphoma Marker), CF405M conjugate, Concentration: 0.1mg/mL |
|||
Granzyme B (NK/T-Cell Lymphoma Marker) Antibody |
|||
BNC051259-500 | Biotium | 500uL | 652.8 EUR |
Description: Primary antibody against Granzyme B (NK/T-Cell Lymphoma Marker), CF405M conjugate, Concentration: 0.1mg/mL |
|||
Granzyme B (NK/T-Cell Lymphoma Marker) Antibody |
|||
BNC041259-100 | Biotium | 100uL | 238.8 EUR |
Description: Primary antibody against Granzyme B (NK/T-Cell Lymphoma Marker), CF405S conjugate, Concentration: 0.1mg/mL |
|||
Granzyme B (NK/T-Cell Lymphoma Marker) Antibody |
|||
BNC041259-500 | Biotium | 500uL | 652.8 EUR |
Description: Primary antibody against Granzyme B (NK/T-Cell Lymphoma Marker), CF405S conjugate, Concentration: 0.1mg/mL |
|||
Granzyme B (NK/T-Cell Lymphoma Marker) Antibody |
|||
BNC401259-100 | Biotium | 100uL | 238.8 EUR |
Description: Primary antibody against Granzyme B (NK/T-Cell Lymphoma Marker), CF640R conjugate, Concentration: 0.1mg/mL |
|||
Granzyme B (NK/T-Cell Lymphoma Marker) Antibody |
|||
BNC401259-500 | Biotium | 500uL | 652.8 EUR |
Description: Primary antibody against Granzyme B (NK/T-Cell Lymphoma Marker), CF640R conjugate, Concentration: 0.1mg/mL |
|||
Granzyme B (NK/T-Cell Lymphoma Marker) Antibody |
|||
BNCB1259-100 | Biotium | 100uL | 238.8 EUR |
Description: Primary antibody against Granzyme B (NK/T-Cell Lymphoma Marker), Biotin conjugate, Concentration: 0.1mg/mL |
|||
Granzyme B (NK/T-Cell Lymphoma Marker) Antibody |
|||
BNCB1259-500 | Biotium | 500uL | 652.8 EUR |
Description: Primary antibody against Granzyme B (NK/T-Cell Lymphoma Marker), Biotin conjugate, Concentration: 0.1mg/mL |
|||
Granzyme B (NK/T-Cell Lymphoma Marker) Antibody |
|||
BNCAP1259-100 | Biotium | 100uL | 238.8 EUR |
Description: Primary antibody against Granzyme B (NK/T-Cell Lymphoma Marker), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
|||
Granzyme B (NK/T-Cell Lymphoma Marker) Antibody |
|||
BNCAP1259-500 | Biotium | 500uL | 652.8 EUR |
Description: Primary antibody against Granzyme B (NK/T-Cell Lymphoma Marker), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
|||
Granzyme B (NK/T-Cell Lymphoma Marker) Antibody |
|||
BNCA1259-250 | Biotium | 250uL | 459.6 EUR |
Description: Primary antibody against Granzyme B (NK/T-Cell Lymphoma Marker), APC conjugate, Concentration: 0.1mg/mL |
|||
Granzyme B (NK/T-Cell Lymphoma Marker) Antibody |
|||
BNCR1259-250 | Biotium | 250uL | 459.6 EUR |
Description: Primary antibody against Granzyme B (NK/T-Cell Lymphoma Marker), RPE conjugate, Concentration: 0.1mg/mL |
|||
Granzyme B (NK/T-Cell Lymphoma Marker) Antibody |
|||
BNCP1259-250 | Biotium | 250uL | 459.6 EUR |
Description: Primary antibody against Granzyme B (NK/T-Cell Lymphoma Marker), PerCP conjugate, Concentration: 0.1mg/mL |
|||
Granzyme B (NK/T-Cell Lymphoma Marker) Antibody |
|||
BNUM1259-50 | Biotium | 50uL | 474 EUR |
Description: Primary antibody against Granzyme B (NK/T-Cell Lymphoma Marker), 1mg/mL |
|||
Granzyme B (NK/T-Cell Lymphoma Marker) Antibody |
|||
BNCH1259-100 | Biotium | 100uL | 238.8 EUR |
Description: Primary antibody against Granzyme B (NK/T-Cell Lymphoma Marker), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL |
|||
Granzyme B (NK/T-Cell Lymphoma Marker) Antibody |
|||
BNCH1259-500 | Biotium | 500uL | 652.8 EUR |
Description: Primary antibody against Granzyme B (NK/T-Cell Lymphoma Marker), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL |
|||
Granzyme B (NK/T-Cell Lymphoma Marker) Antibody |
|||
BNUB1259-100 | Biotium | 100uL | 250.8 EUR |
Description: Primary antibody against Granzyme B (NK/T-Cell Lymphoma Marker), Concentration: 0.2mg/mL |
|||
Granzyme B (NK/T-Cell Lymphoma Marker) Antibody |
|||
BNUB1259-500 | Biotium | 500uL | 549.6 EUR |
Description: Primary antibody against Granzyme B (NK/T-Cell Lymphoma Marker), Concentration: 0.2mg/mL |
|||
Granzyme B (NK/T-Cell Lymphoma Marker) Antibody |
|||
BNC611259-100 | Biotium | 100uL | 238.8 EUR |
Description: Primary antibody against Granzyme B (NK/T-Cell Lymphoma Marker), CF660R conjugate, Concentration: 0.1mg/mL |
|||
Granzyme B (NK/T-Cell Lymphoma Marker) Antibody |
|||
BNC611259-500 | Biotium | 500uL | 652.8 EUR |
Description: Primary antibody against Granzyme B (NK/T-Cell Lymphoma Marker), CF660R conjugate, Concentration: 0.1mg/mL |
|||
Granzyme B (NK/T-Cell Lymphoma Marker) Antibody |
|||
BNC551259-100 | Biotium | 100uL | 238.8 EUR |
Description: Primary antibody against Granzyme B (NK/T-Cell Lymphoma Marker), CF555 conjugate, Concentration: 0.1mg/mL |
|||
Granzyme B (NK/T-Cell Lymphoma Marker) Antibody |
|||
BNC551259-500 | Biotium | 500uL | 652.8 EUR |
Description: Primary antibody against Granzyme B (NK/T-Cell Lymphoma Marker), CF555 conjugate, Concentration: 0.1mg/mL |
|||
Granzyme B (NK/T-Cell Lymphoma Marker) Antibody |
|||
BNC431259-100 | Biotium | 100uL | 238.8 EUR |
Description: Primary antibody against Granzyme B (NK/T-Cell Lymphoma Marker), CF543 conjugate, Concentration: 0.1mg/mL |
|||
Granzyme B (NK/T-Cell Lymphoma Marker) Antibody |
|||
BNC431259-500 | Biotium | 500uL | 652.8 EUR |
Description: Primary antibody against Granzyme B (NK/T-Cell Lymphoma Marker), CF543 conjugate, Concentration: 0.1mg/mL |
|||
Granzyme B (NK/T-Cell Lymphoma Marker) Antibody |
|||
BNC681259-100 | Biotium | 100uL | 238.8 EUR |
Description: Primary antibody against Granzyme B (NK/T-Cell Lymphoma Marker), CF568 conjugate, Concentration: 0.1mg/mL |
|||
Granzyme B (NK/T-Cell Lymphoma Marker) Antibody |
|||
BNC681259-500 | Biotium | 500uL | 652.8 EUR |
Description: Primary antibody against Granzyme B (NK/T-Cell Lymphoma Marker), CF568 conjugate, Concentration: 0.1mg/mL |
|||
Granzyme B (NK/T-Cell Lymphoma Marker) Antibody |
|||
BNC471259-100 | Biotium | 100uL | 238.8 EUR |
Description: Primary antibody against Granzyme B (NK/T-Cell Lymphoma Marker), CF647 conjugate, Concentration: 0.1mg/mL |
|||
Granzyme B (NK/T-Cell Lymphoma Marker) Antibody |
|||
BNC471259-500 | Biotium | 500uL | 652.8 EUR |
Description: Primary antibody against Granzyme B (NK/T-Cell Lymphoma Marker), CF647 conjugate, Concentration: 0.1mg/mL |
|||
CD57 / B3GAT1 (Natural Killer Cell Marker); Clone HNK-1 & NK-1 (Concentrate) |
|||
RA0357-C.1 | ScyTek Laboratories | 0.1 ml | 150 EUR |
CD57 / B3GAT1 (Natural Killer Cell Marker); Clone HNK-1 & NK-1 (Concentrate) |
|||
RA0357-C.5 | ScyTek Laboratories | 0.5 ml | 296.4 EUR |
Monoclonal CD57 / B3GAT1 (Natural Killer Cell Marker) Antibody, Clone: HNK-1 + NK-1 |
|||
AMM00758G | Leading Biology | 7 ml | 580.8 EUR |
Description: A Monoclonal antibody against Human CD57 / B3GAT1 (Natural Killer Cell Marker). The antibodies are raised in Mouse and are from clone HNK-1 + NK-1. This antibody is applicable in IHC, IF |
|||
Granzyme B (NK/T-Cell Lymphoma Marker) (GZMB/2403) Antibody |
|||
BNC942403-100 | Biotium | 100uL | 279.6 EUR |
Description: Primary antibody against Granzyme B (NK/T-Cell Lymphoma Marker) (GZMB/2403), CF594 conjugate, Concentration: 0.1mg/mL |
|||
Granzyme B (NK/T-Cell Lymphoma Marker) (GZMB/2403) Antibody |
|||
BNC942403-500 | Biotium | 500uL | 654 EUR |
Description: Primary antibody against Granzyme B (NK/T-Cell Lymphoma Marker) (GZMB/2403), CF594 conjugate, Concentration: 0.1mg/mL |
|||
Granzyme B (NK/T-Cell Lymphoma Marker) (GZMB/2403) Antibody |
|||
BNC802403-100 | Biotium | 100uL | 279.6 EUR |
Description: Primary antibody against Granzyme B (NK/T-Cell Lymphoma Marker) (GZMB/2403), CF680 conjugate, Concentration: 0.1mg/mL |
|||
Granzyme B (NK/T-Cell Lymphoma Marker) (GZMB/2403) Antibody |
|||
BNC802403-500 | Biotium | 500uL | 654 EUR |
Description: Primary antibody against Granzyme B (NK/T-Cell Lymphoma Marker) (GZMB/2403), CF680 conjugate, Concentration: 0.1mg/mL |
|||
Granzyme B (NK/T-Cell Lymphoma Marker) (GZMB/2403) Antibody |
|||
BNC702403-100 | Biotium | 100uL | 279.6 EUR |
Description: Primary antibody against Granzyme B (NK/T-Cell Lymphoma Marker) (GZMB/2403), CF770 conjugate, Concentration: 0.1mg/mL |
|||
Granzyme B (NK/T-Cell Lymphoma Marker) (GZMB/2403) Antibody |
|||
BNC702403-500 | Biotium | 500uL | 654 EUR |
Description: Primary antibody against Granzyme B (NK/T-Cell Lymphoma Marker) (GZMB/2403), CF770 conjugate, Concentration: 0.1mg/mL |
|||
Granzyme B (NK/T-Cell Lymphoma Marker) (GZMB/2403) Antibody |
|||
BNC882403-100 | Biotium | 100uL | 279.6 EUR |
Description: Primary antibody against Granzyme B (NK/T-Cell Lymphoma Marker) (GZMB/2403), CF488A conjugate, Concentration: 0.1mg/mL |
|||
Granzyme B (NK/T-Cell Lymphoma Marker) (GZMB/2403) Antibody |
|||
BNC882403-500 | Biotium | 500uL | 654 EUR |
Description: Primary antibody against Granzyme B (NK/T-Cell Lymphoma Marker) (GZMB/2403), CF488A conjugate, Concentration: 0.1mg/mL |
|||
Granzyme B (NK/T-Cell Lymphoma Marker) (GZMB/2403) Antibody |
|||
BNC812403-100 | Biotium | 100uL | 279.6 EUR |
Description: Primary antibody against Granzyme B (NK/T-Cell Lymphoma Marker) (GZMB/2403), CF680R conjugate, Concentration: 0.1mg/mL |
|||
Granzyme B (NK/T-Cell Lymphoma Marker) (GZMB/2403) Antibody |
|||
BNC812403-500 | Biotium | 500uL | 654 EUR |
Description: Primary antibody against Granzyme B (NK/T-Cell Lymphoma Marker) (GZMB/2403), CF680R conjugate, Concentration: 0.1mg/mL |
|||
Granzyme B (NK/T-Cell Lymphoma Marker) (GZMB/2403) Antibody |
|||
BNC402403-100 | Biotium | 100uL | 279.6 EUR |
Description: Primary antibody against Granzyme B (NK/T-Cell Lymphoma Marker) (GZMB/2403), CF640R conjugate, Concentration: 0.1mg/mL |
|||
Granzyme B (NK/T-Cell Lymphoma Marker) (GZMB/2403) Antibody |
|||
BNC402403-500 | Biotium | 500uL | 654 EUR |
Description: Primary antibody against Granzyme B (NK/T-Cell Lymphoma Marker) (GZMB/2403), CF640R conjugate, Concentration: 0.1mg/mL |
|||
Granzyme B (NK/T-Cell Lymphoma Marker) (GZMB/2403) Antibody |
|||
BNC052403-100 | Biotium | 100uL | 279.6 EUR |
Description: Primary antibody against Granzyme B (NK/T-Cell Lymphoma Marker) (GZMB/2403), CF405M conjugate, Concentration: 0.1mg/mL |
|||
Granzyme B (NK/T-Cell Lymphoma Marker) (GZMB/2403) Antibody |
|||
BNC052403-500 | Biotium | 500uL | 654 EUR |
Description: Primary antibody against Granzyme B (NK/T-Cell Lymphoma Marker) (GZMB/2403), CF405M conjugate, Concentration: 0.1mg/mL |
|||
Granzyme B (NK/T-Cell Lymphoma Marker) (GZMB/2403) Antibody |
|||
BNC042403-100 | Biotium | 100uL | 279.6 EUR |
Description: Primary antibody against Granzyme B (NK/T-Cell Lymphoma Marker) (GZMB/2403), CF405S conjugate, Concentration: 0.1mg/mL |
|||
Granzyme B (NK/T-Cell Lymphoma Marker) (GZMB/2403) Antibody |
|||
BNC042403-500 | Biotium | 500uL | 654 EUR |
Description: Primary antibody against Granzyme B (NK/T-Cell Lymphoma Marker) (GZMB/2403), CF405S conjugate, Concentration: 0.1mg/mL |
|||
Granzyme B (NK/T-Cell Lymphoma Marker) (GZMB/2403) Antibody |
|||
BNCAP2403-100 | Biotium | 100uL | 279.6 EUR |
Description: Primary antibody against Granzyme B (NK/T-Cell Lymphoma Marker) (GZMB/2403), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
|||
Granzyme B (NK/T-Cell Lymphoma Marker) (GZMB/2403) Antibody |
|||
BNCAP2403-500 | Biotium | 500uL | 654 EUR |
Description: Primary antibody against Granzyme B (NK/T-Cell Lymphoma Marker) (GZMB/2403), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
|||
Granzyme B (NK/T-Cell Lymphoma Marker) (GZMB/2403) Antibody |
|||
BNCA2403-250 | Biotium | 250uL | 472.8 EUR |
Description: Primary antibody against Granzyme B (NK/T-Cell Lymphoma Marker) (GZMB/2403), APC conjugate, Concentration: 0.1mg/mL |
|||
Granzyme B (NK/T-Cell Lymphoma Marker) (GZMB/2403) Antibody |
|||
BNCP2403-250 | Biotium | 250uL | 472.8 EUR |
Description: Primary antibody against Granzyme B (NK/T-Cell Lymphoma Marker) (GZMB/2403), PerCP conjugate, Concentration: 0.1mg/mL |
|||
Granzyme B (NK/T-Cell Lymphoma Marker) (GZMB/2403) Antibody |
|||
BNCR2403-250 | Biotium | 250uL | 472.8 EUR |
Description: Primary antibody against Granzyme B (NK/T-Cell Lymphoma Marker) (GZMB/2403), RPE conjugate, Concentration: 0.1mg/mL |
|||
Granzyme B (NK/T-Cell Lymphoma Marker) (GZMB/2403) Antibody |
|||
BNCH2403-100 | Biotium | 100uL | 279.6 EUR |
Description: Primary antibody against Granzyme B (NK/T-Cell Lymphoma Marker) (GZMB/2403), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL |
|||
Granzyme B (NK/T-Cell Lymphoma Marker) (GZMB/2403) Antibody |
|||
BNCH2403-500 | Biotium | 500uL | 654 EUR |
Description: Primary antibody against Granzyme B (NK/T-Cell Lymphoma Marker) (GZMB/2403), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL |
|||
Granzyme B (NK/T-Cell Lymphoma Marker) (GZMB/2403) Antibody |
|||
BNCB2403-100 | Biotium | 100uL | 279.6 EUR |
Description: Primary antibody against Granzyme B (NK/T-Cell Lymphoma Marker) (GZMB/2403), Biotin conjugate, Concentration: 0.1mg/mL |
|||
Granzyme B (NK/T-Cell Lymphoma Marker) (GZMB/2403) Antibody |
|||
BNCB2403-500 | Biotium | 500uL | 654 EUR |
Description: Primary antibody against Granzyme B (NK/T-Cell Lymphoma Marker) (GZMB/2403), Biotin conjugate, Concentration: 0.1mg/mL |
|||
Granzyme B (NK/T-Cell Lymphoma Marker) (GZMB/2403) Antibody |
|||
BNUB2403-100 | Biotium | 100uL | 316.8 EUR |
Description: Primary antibody against Granzyme B (NK/T-Cell Lymphoma Marker) (GZMB/2403), Concentration: 0.2mg/mL |
|||
Granzyme B (NK/T-Cell Lymphoma Marker) (GZMB/2403) Antibody |
|||
BNUB2403-50 | Biotium | 50uL | 486 EUR |
Description: Primary antibody against Granzyme B (NK/T-Cell Lymphoma Marker) (GZMB/2403), 1mg/mL |
|||
Granzyme B (NK/T-Cell Lymphoma Marker) (GZMB/2403) Antibody |
|||
BNUB2403-500 | Biotium | 500uL | 615.6 EUR |
Description: Primary antibody against Granzyme B (NK/T-Cell Lymphoma Marker) (GZMB/2403), Concentration: 0.2mg/mL |
|||
Granzyme B (NK/T-Cell Lymphoma Marker) (GZMB/2403) Antibody |
|||
BNC472403-100 | Biotium | 100uL | 279.6 EUR |
Description: Primary antibody against Granzyme B (NK/T-Cell Lymphoma Marker) (GZMB/2403), CF647 conjugate, Concentration: 0.1mg/mL |
|||
Granzyme B (NK/T-Cell Lymphoma Marker) (GZMB/2403) Antibody |
|||
BNC472403-500 | Biotium | 500uL | 654 EUR |
Description: Primary antibody against Granzyme B (NK/T-Cell Lymphoma Marker) (GZMB/2403), CF647 conjugate, Concentration: 0.1mg/mL |
|||
Granzyme B (NK/T-Cell Lymphoma Marker) (GZMB/2403) Antibody |
|||
BNC552403-100 | Biotium | 100uL | 279.6 EUR |
Description: Primary antibody against Granzyme B (NK/T-Cell Lymphoma Marker) (GZMB/2403), CF555 conjugate, Concentration: 0.1mg/mL |
|||
Granzyme B (NK/T-Cell Lymphoma Marker) (GZMB/2403) Antibody |
|||
BNC552403-500 | Biotium | 500uL | 654 EUR |
Description: Primary antibody against Granzyme B (NK/T-Cell Lymphoma Marker) (GZMB/2403), CF555 conjugate, Concentration: 0.1mg/mL |
|||
Granzyme B (NK/T-Cell Lymphoma Marker) (GZMB/2403) Antibody |
|||
BNC612403-100 | Biotium | 100uL | 279.6 EUR |
Description: Primary antibody against Granzyme B (NK/T-Cell Lymphoma Marker) (GZMB/2403), CF660R conjugate, Concentration: 0.1mg/mL |
|||
Granzyme B (NK/T-Cell Lymphoma Marker) (GZMB/2403) Antibody |
|||
BNC612403-500 | Biotium | 500uL | 654 EUR |
Description: Primary antibody against Granzyme B (NK/T-Cell Lymphoma Marker) (GZMB/2403), CF660R conjugate, Concentration: 0.1mg/mL |
|||
Granzyme B (NK/T-Cell Lymphoma Marker) (GZMB/2403) Antibody |
|||
BNC432403-100 | Biotium | 100uL | 279.6 EUR |
Description: Primary antibody against Granzyme B (NK/T-Cell Lymphoma Marker) (GZMB/2403), CF543 conjugate, Concentration: 0.1mg/mL |
|||
Granzyme B (NK/T-Cell Lymphoma Marker) (GZMB/2403) Antibody |
|||
BNC432403-500 | Biotium | 500uL | 654 EUR |
Description: Primary antibody against Granzyme B (NK/T-Cell Lymphoma Marker) (GZMB/2403), CF543 conjugate, Concentration: 0.1mg/mL |
|||
Granzyme B (NK/T-Cell Lymphoma Marker) (GZMB/2403) Antibody |
|||
BNC682403-100 | Biotium | 100uL | 279.6 EUR |
Description: Primary antibody against Granzyme B (NK/T-Cell Lymphoma Marker) (GZMB/2403), CF568 conjugate, Concentration: 0.1mg/mL |
|||
Granzyme B (NK/T-Cell Lymphoma Marker) (GZMB/2403) Antibody |
|||
BNC682403-500 | Biotium | 500uL | 654 EUR |
Description: Primary antibody against Granzyme B (NK/T-Cell Lymphoma Marker) (GZMB/2403), CF568 conjugate, Concentration: 0.1mg/mL |
|||
Plasma Cell Marker Antibody |
|||
V9116-100UG | NSJ Bioreagents | 100 ug | 349.3 EUR |
Description: It recognizes an intra-cytoplasmic antigen, which shows a very high degree of specificity for plasma cells. This antigen is present in normal as well as neoplastic plasma cells. Plasma cells, which are large lymphocytes derived from an antigen-specific B cell, secrete antibodies and are responsible for humoral immunity. Plasma cells differentiate from B cells upon stimulation by CD4+ lymphocytes. The B cell acts as an antigen-presenting cell (APC), consuming an offending pathogen, which is taken up by the B cell by phagocytosis and broken down within proteosomes. Plasma cells contain basophilic cytoplasm; their nucleus contains heterochromatin organized in a characteristic cartwheel arrangement. This mAb superbly recognizes normal and neoplastic plasma cells in routine formalin-fixed, paraffin-embedded tissue sections. It is of potential value in identifying myeloma or plasmacytoma in bone marrow or other tissues. It also helps differentiate lympho-plasmacytoid lymphoma from lymphocytic and follicular lymphoma. |
|||
Plasma Cell Marker Antibody |
|||
V9116-20UG | NSJ Bioreagents | 20 ug | 153.3 EUR |
Description: It recognizes an intra-cytoplasmic antigen, which shows a very high degree of specificity for plasma cells. This antigen is present in normal as well as neoplastic plasma cells. Plasma cells, which are large lymphocytes derived from an antigen-specific B cell, secrete antibodies and are responsible for humoral immunity. Plasma cells differentiate from B cells upon stimulation by CD4+ lymphocytes. The B cell acts as an antigen-presenting cell (APC), consuming an offending pathogen, which is taken up by the B cell by phagocytosis and broken down within proteosomes. Plasma cells contain basophilic cytoplasm; their nucleus contains heterochromatin organized in a characteristic cartwheel arrangement. This mAb superbly recognizes normal and neoplastic plasma cells in routine formalin-fixed, paraffin-embedded tissue sections. It is of potential value in identifying myeloma or plasmacytoma in bone marrow or other tissues. It also helps differentiate lympho-plasmacytoid lymphoma from lymphocytic and follicular lymphoma. |
|||
Plasma Cell Marker Antibody |
|||
V9116IHC-7ML | NSJ Bioreagents | 7 ml | 349.3 EUR |
Description: It recognizes an intra-cytoplasmic antigen, which shows a very high degree of specificity for plasma cells. This antigen is present in normal as well as neoplastic plasma cells. Plasma cells, which are large lymphocytes derived from an antigen-specific B cell, secrete antibodies and are responsible for humoral immunity. Plasma cells differentiate from B cells upon stimulation by CD4+ lymphocytes. The B cell acts as an antigen-presenting cell (APC), consuming an offending pathogen, which is taken up by the B cell by phagocytosis and broken down within proteosomes. Plasma cells contain basophilic cytoplasm; their nucleus contains heterochromatin organized in a characteristic cartwheel arrangement. This mAb superbly recognizes normal and neoplastic plasma cells in routine formalin-fixed, paraffin-embedded tissue sections. It is of potential value in identifying myeloma or plasmacytoma in bone marrow or other tissues. It also helps differentiate lympho-plasmacytoid lymphoma from lymphocytic and follicular lymphoma. |
|||
Plasma Cell Marker Antibody |
|||
V9116SAF-100UG | NSJ Bioreagents | 100 ug | 349.3 EUR |
Description: It recognizes an intra-cytoplasmic antigen, which shows a very high degree of specificity for plasma cells. This antigen is present in normal as well as neoplastic plasma cells. Plasma cells, which are large lymphocytes derived from an antigen-specific B cell, secrete antibodies and are responsible for humoral immunity. Plasma cells differentiate from B cells upon stimulation by CD4+ lymphocytes. The B cell acts as an antigen-presenting cell (APC), consuming an offending pathogen, which is taken up by the B cell by phagocytosis and broken down within proteosomes. Plasma cells contain basophilic cytoplasm; their nucleus contains heterochromatin organized in a characteristic cartwheel arrangement. This mAb superbly recognizes normal and neoplastic plasma cells in routine formalin-fixed, paraffin-embedded tissue sections. It is of potential value in identifying myeloma or plasmacytoma in bone marrow or other tissues. It also helps differentiate lympho-plasmacytoid lymphoma from lymphocytic and follicular lymphoma. |
|||
Plasma Cell Marker Antibody |
|||
V2360-100UG | NSJ Bioreagents | 100 ug | 349.3 EUR |
Description: This antibody recognizes an intra-cytoplasmic marker antigen which shows a very high degree of specificity for plasma cells. This marker protein is present in normal as well as neoplastic plasma cells. Plasma cells, which are large lymphocytes derived from an antigen-specific B cell, secrete antibodies and are responsible for humoral immunity. Plasma cells differentiate from B cells upon stimulation by CD4+ lymphocytes. The B cell acts as an antigen-presenting cell (APC), consuming an offending pathogen, which is taken up by the B cell by phagocytosis and broken down within proteosomes. Plasma cells contain basophilic cytoplasm; their nucleus contains heterochromatin organized in a characteristic cartwheel arrangement. This marker antibody superbly recognizes normal and neoplastic plasma cells in routine formalin/paraffin tissue sections. It is of potential value in identifying myeloma or plasmacytoma in bone marrow or other tissues. It also helps differentiate lympho-plasmacytoid lymphoma from lymphocytic and follicular lymphoma. Note that this plasma cell marker antibody is not suitable for staining frozen tissues. |
|||
Plasma Cell Marker Antibody |
|||
V2360-20UG | NSJ Bioreagents | 20 ug | 153.3 EUR |
Description: This antibody recognizes an intra-cytoplasmic marker antigen which shows a very high degree of specificity for plasma cells. This marker protein is present in normal as well as neoplastic plasma cells. Plasma cells, which are large lymphocytes derived from an antigen-specific B cell, secrete antibodies and are responsible for humoral immunity. Plasma cells differentiate from B cells upon stimulation by CD4+ lymphocytes. The B cell acts as an antigen-presenting cell (APC), consuming an offending pathogen, which is taken up by the B cell by phagocytosis and broken down within proteosomes. Plasma cells contain basophilic cytoplasm; their nucleus contains heterochromatin organized in a characteristic cartwheel arrangement. This marker antibody superbly recognizes normal and neoplastic plasma cells in routine formalin/paraffin tissue sections. It is of potential value in identifying myeloma or plasmacytoma in bone marrow or other tissues. It also helps differentiate lympho-plasmacytoid lymphoma from lymphocytic and follicular lymphoma. Note that this plasma cell marker antibody is not suitable for staining frozen tissues. |
|||
Plasma Cell Marker Antibody |
|||
V2360IHC-7ML | NSJ Bioreagents | 7 ml | 349.3 EUR |
Description: This antibody recognizes an intra-cytoplasmic marker antigen which shows a very high degree of specificity for plasma cells. This marker protein is present in normal as well as neoplastic plasma cells. Plasma cells, which are large lymphocytes derived from an antigen-specific B cell, secrete antibodies and are responsible for humoral immunity. Plasma cells differentiate from B cells upon stimulation by CD4+ lymphocytes. The B cell acts as an antigen-presenting cell (APC), consuming an offending pathogen, which is taken up by the B cell by phagocytosis and broken down within proteosomes. Plasma cells contain basophilic cytoplasm; their nucleus contains heterochromatin organized in a characteristic cartwheel arrangement. This marker antibody superbly recognizes normal and neoplastic plasma cells in routine formalin/paraffin tissue sections. It is of potential value in identifying myeloma or plasmacytoma in bone marrow or other tissues. It also helps differentiate lympho-plasmacytoid lymphoma from lymphocytic and follicular lymphoma. Note that this plasma cell marker antibody is not suitable for staining frozen tissues. |
|||
Plasma Cell Marker Antibody |
|||
V2360SAF-100UG | NSJ Bioreagents | 100 ug | 349.3 EUR |
Description: This antibody recognizes an intra-cytoplasmic marker antigen which shows a very high degree of specificity for plasma cells. This marker protein is present in normal as well as neoplastic plasma cells. Plasma cells, which are large lymphocytes derived from an antigen-specific B cell, secrete antibodies and are responsible for humoral immunity. Plasma cells differentiate from B cells upon stimulation by CD4+ lymphocytes. The B cell acts as an antigen-presenting cell (APC), consuming an offending pathogen, which is taken up by the B cell by phagocytosis and broken down within proteosomes. Plasma cells contain basophilic cytoplasm; their nucleus contains heterochromatin organized in a characteristic cartwheel arrangement. This marker antibody superbly recognizes normal and neoplastic plasma cells in routine formalin/paraffin tissue sections. It is of potential value in identifying myeloma or plasmacytoma in bone marrow or other tissues. It also helps differentiate lympho-plasmacytoid lymphoma from lymphocytic and follicular lymphoma. Note that this plasma cell marker antibody is not suitable for staining frozen tissues. |
|||
293AD Cell Line |
|||
AD-100 | Cell Biolabs | 1 vial | 553.2 EUR |
Description: The 293AD Cell Line is derived from the parental 293 cells but selected for attributes that increase adenovirus production, including firmer attachment and larger surface area. |
|||
293AAV Cell Line |
|||
AAV-100 | Cell Biolabs | 1 vial | 609.6 EUR |
Description: The 293AAV Cell Line is derived from the parental 293 cells but selected for attributes that increase AAV production, including firmer attachment and larger surface area. |
|||
293LTV Cell Line |
|||
LTV-100 | Cell Biolabs | 1 vial | 609.6 EUR |
Description: The 293LTV Cell Line is derived from the parental 293 cells but selected for attributes that increase lentiviral production, including fimrer attachment and larger surface area. |
|||
293RTV Cell Line |
|||
RV-100 | Cell Biolabs | 1 vial | 609.6 EUR |
Description: The 293RTV Cell Line is derived from the parental 293 cells but selected for attributes that increase retroviral production, including fimrer attachment and larger surface area. |